Faes Farma to Acquire SIFI to Build Leading Ophthalmology Franchise
June 10, 2025
SIFI shareholders have signed an agreement to sell 100% of SIFI shares to Faes Farma, a European pharmaceutical company listed on the Spanish stock exchange. The deal is expected to close in Q3 2025, subject to regulatory approvals and Faes Farma’s extraordinary shareholders’ meeting.
- Buyers
- Faes Farma
- Targets
- SIFI
- Sellers
- SIFI shareholders (founding families and 21 Invest SGR S.p.A. on behalf of the managed fund 21 Investimenti III)
- Industry
- Healthcare Services
- Location
- Italy
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Alfasigma to Acquire Nordic Group B.V. (Nordic Pharma)
August 11, 2026
Pharmaceuticals
Alfasigma S.p.A. has entered into a share purchase agreement with SEVER Life Sciences B.V. to acquire 100% of the shares of Nordic Group B.V. and its subsidiaries (Nordic Pharma). The deal will expand Alfasigma’s specialty rheumatology offering, including Nordic Pharma’s rheumatoid arthritis Nordimet (methotrexate) franchise, while also strengthening its commercial footprint in Europe, Canada, and Japan.
-
EssilorLuxottica Acquires Faro, an Italian High-Precision CNC Machinery Maker for Eyewear Manufacturing
April 28, 2026
Industrial Services
EssilorLuxottica has acquired Faro, an Italian company with 20+ years of expertise in designing, manufacturing, and distributing high-precision CNC machinery used for milling and diamond cutting for the jewelry and eyewear industries. The acquisition is intended to deepen EssilorLuxottica’s vertical integration by adding precision manufacturing technology capabilities, while giving Faro access to EssilorLuxottica’s global resources for long-term growth.
-
Lupin Acquires VISUfarma from GHO Capital
September 29, 2025
Healthcare Services
Lupin Limited, through its wholly owned subsidiary Nanomi B.V., signed a definitive agreement to acquire VISUfarma B.V. from healthcare investor GHO Capital Partners LLP. The acquisition expands Lupin’s specialty ophthalmology franchise by adding a portfolio of 60+ branded eye health products and established commercial operations across major European markets.
-
Azelis Acquires Azienda Chimica e Farmaceutica (ACEF)
July 9, 2025
Industrial Services
Azelis Group NV has acquired 100% of Azienda Chimica e Farmaceutica (ACEF), a Piacenza-based distributor of specialty raw materials and ingredients for the cosmetic, nutraceutical, galenic and pharmaceutical markets. The acquisition strengthens Azelis's footprint in Italy, expands its product portfolio and technical capabilities, and brings ACEF's laboratories and GMP-compliant facilities into Azelis's network.
-
EssilorLuxottica to Acquire Optegra Eye Clinics from MidEuropa
May 30, 2025
Healthcare Services
EssilorLuxottica has agreed to acquire Optegra, a European ophthalmology platform operating over 70 eye hospitals and diagnostic facilities across the UK, Czech Republic, Poland, Slovakia, and the Netherlands. The deal follows Optegra’s expansion under MidEuropa’s ownership and is expected to close later in 2025, pending regulatory approvals and customary closing conditions.
-
Roquette To Acquire IFF Pharma Solutions in Up to $2.85 Billion Deal
March 20, 2024
Pharmaceuticals
IFF has entered into a definitive agreement to sell its Pharma Solutions business unit to Roquette for an enterprise value of up to $2.85 billion. The transaction is expected to close in the first half of 2025, subject to customary closing conditions and regulatory approvals.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.